3-AMINO-7-METHYL-[1,2,4]TRIAZOLO[4,3-A]PYRIMIDIN-5-OL
- $378 - $778
- Product name: 3-AMINO-7-METHYL-[1,2,4]TRIAZOLO[4,3-A]PYRIMIDIN-5-OL
- CAS: 13223-34-2
- MF: C6H7N5O
- MW: 165.15
- EINECS:
- MDL Number:MFCD06011096
- Synonyms:3-AMINO-7-METHYL-[1,2,4]TRIAZOLO[4,3-A]PYRIMIDIN-5-OL;3-amino-7-methyl-8H-[1,2,4]triazolo[4,3-a]pyrimidin-5-one;1,2,4-Triazolo[4,3-a]pyrimidin-5-ol, 3-amino-7-methyl-
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAK Scientific
- Product number3742AD
- Product description3-Amino-7-methyl-[1,2,4]triazolo[4,3-a]pyrimidin-5-ol
- Packaging1g
- Price$560
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0090491
- Product description3-AMINO-7-METHYL-[1,2,4]TRIAZOLO[4,3-A]PYRIMIDIN-5-OL 95.00%
- Packaging500MG
- Price$773.85
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11294671
- Product description3-Amino-7-methyl-[1,2,4]triazolo[4,3-a]pyrimidin-5-ol 97%
- Packaging5g
- Price$778
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number012743
- Product description3-Amino-7-methyl-[1,2,4]triazolo[4,3-a]pyrimidin-5-ol
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 3742AD | 3-Amino-7-methyl-[1,2,4]triazolo[4,3-a]pyrimidin-5-ol | 1g | $560 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0090491 | 3-AMINO-7-METHYL-[1,2,4]TRIAZOLO[4,3-A]PYRIMIDIN-5-OL 95.00% | 500MG | $773.85 | 2021-12-16 | Buy |
Crysdot | CD11294671 | 3-Amino-7-methyl-[1,2,4]triazolo[4,3-a]pyrimidin-5-ol 97% | 5g | $778 | 2021-12-16 | Buy |
Matrix Scientific | 012743 | 3-Amino-7-methyl-[1,2,4]triazolo[4,3-a]pyrimidin-5-ol | 1g | $378 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|